Faculty of Biology, Medicine and Health

The University of Manchester

  Understanding how to target the T cell compartment within related brain tumours

  , , Dr Omar Pathmanaban  Applications accepted all year round  Self-Funded PhD Students Only

About the Project

T cell-based immunotherapy has revolutionised the treatment of many different types of cancer. However, to date, these treatments have not been successful or widely used for the treatment of brain tumours. The rare disease NF2 schwannomatosis (NF2-SWN) is characterised by the development of various different types of tumours within the skull, including vestibular schwannoma, meningioma and ependymomas. These tumours cause substantial suffering, limit the quality of life of patients, and can be fatal. At present there are currently no treatments that effectively target all the different types of tumour that form in a patient at the same time.

In this project the student will dissect the nature of the T cell compartment within NF2-SWN-related brain tumours. Working within clinicians, neurosurgeons and basic neuroimmunologists within the Geoffrey Jefferson Brain Research Centre, the student will employ high dimensional imaging and phenotyping approaches to reveal the core signatures of the T cells within the different tumours, focussing on the effector, memory and exhaustion programmes exhibited by the cells. The student will also utilise existing transcriptomics datasets to define the comparable and distinct pathways that influence T cell function and behaviour within the different brain tumours. This will include focussing on the nature of communication between myeloid cells, stromal cells and neoplastic cells with T cell populations within the tumour microenvironment. Collectively, these analyses will prioritise treatment approaches to reinvigorate T cell responses during NF2-SWN tumours, which will be trialled within pre-clinical in vivo models.

Training/techniques to be provided:

The successful candidate will receive training in various cutting edge immunological techniques including imaging mass cytometry, flow cytometry, spectral flow cytometry, confocal and immunofluorescence microscopy, all combined with in vivo training. Associated with this work will be the development of excellent in vivo skills as well as in vitro use of cellular activation assays.

The student will become proficient in quantitative analyses of high-dimensional images, which will require developing expertise in statistics and computation. The student will utilise a number of existing RNA-seq libraries in their studies, providing experience and trainingin bioinformatics.

Thus, the successful candidate will obtain essential interdisciplinary and quantitative in vivo skills to support their future career. The student will be embedded within the wider neuroimmunology groups at the University and within the Geoffrey Jefferson Brain Research Centre, which will provide the student with outstanding further opportunities to increase their wider knowledge of immuno-oncology to develop their project through expert collaborations.

Entry requirements

Candidates are expected to hold (or be about to obtain) a minimum upper second class honours degree (or equivalent) in Biology, Immunology or a related subject.

Before you Apply

Applicants must make direct contact with preferred supervisors before applying. It is your responsibility to make arrangements to meet with potential supervisors, prior to submitting a formal online application.

How To Apply

For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website (https://www.bmh.manchester.ac.uk/study/research/apply/). Informal enquiries may be made directly to the primary supervisor. On the online application form select PhD Immunology.

For international students, we also offer a unique 4 year PhD programme that gives you the opportunity to undertake an accredited Teaching Certificate whilst carrying out an independent research project across a range of biological, medical and health sciences. For more information please visit https://www.bmh.manchester.ac.uk/study/research/programmes/integrated-teaching/

Your application form must be accompanied by a number of supporting documents by the advertised deadlines. Without all the required documents submitted at the time of application, your application will not be processed and we cannot accept responsibility for late or missed deadlines. Incomplete applications will not be considered.

If you have any queries regarding making an application please contact our admissions team .

Equality, Diversity and Inclusion

Equality, diversity and inclusion is fundamental to the success of The University of Manchester, and is at the heart of all of our activities. The full Equality, diversity and inclusion statement can be found on the website https://www.bmh.manchester.ac.uk/study/research/apply/equality-diversity-inclusion/

Biological Sciences (4)

Funding Notes

Applications are invited from self-funded students. This project has a Band 3 fee. Details of our different fee bands can be found on our website View Website

References

Hypoxia coordinates the spatial landscape of myeloid cells within glioblastoma to affect survival
Haley, M. J., Bere, L., Minshull, J., Georgaka, S., Garcia Martin, N., Howell, G., Coope, D., Roncaroli, F., King, A., Wedge, D. C., Allan, S. M., Pathmanaban, O. N., Brough, D. & Couper, K. N., 1 Apr 2024, (Accepted/In press) In: Science Advances.
Increased Circulating Chemokines and Macrophage Recruitment in Growing Vestibular Schwannomas
Hannan, C. J., Lewis, D., O'Leary, C., Waqar, M., Brough, D., Couper, K. N., Dyer, D. P., Vail, A., Heal, C., Macarthur, J., Cooper, C., Hammerbeck-Ward, C., Evans, D. G., Rutherford, S. A., Lloyd, S. K., Mackenzie Freeman, S. R., Coope, D. J., King, A. T. & Pathmanaban, O. N., 1 Mar 2023, In: Neurosurgery. 92, 3, p. 581-589 9 p.
The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis
Gregory, G. E., Islim, A. I., Hannan, C. J., Jones, A. P., Hammerbeck-Ward, C., Rutherford, S. A., Freeman, S. R., Lloyd, S., Kalamarides, M., Smith, M. J., Couper, K., McBain, C. A., Jenkinson, M. D., Brough, D., King, A. T., Evans, D. G. & Pathmanaban, O. N., 3 Jun 2023, In: Neuro-Oncology Advances. 5, Suppl 1, p. i94-i104
The comparable tumour microenvironment in sporadic and NF2-related schwannomatosis vestibular schwannoma
Gregory, G. E., Jones, A. P., Haley, M. J., Hoyle, C., Zeef, L. A. H., Lin, I-H., Coope, D. J., King, A. T., Evans, D. G., Paszek, P., Couper, K. N., Brough, D. & Pathmanaban, O. N., 21 Jul 2023, In: Brain Communications. 5, 4, fcad197.

Register your interest for this project



Where will I study?

Faculty of Biology, Medicine and Health

Tackle real world challenges, make a difference, and elevate your career with postgraduate research in the Faculty of Biology, Medicine and Health at Manchester. From biochemistry to neuroscience, cancer sciences to medicine, audiology to mental health and everything in between, we offer a wide range of postgraduate research projects, programmes and funding which will allow you to immerse yourself in an area of research you’re passionate about.

Why study at Faculty of Biology, Medicine and Health?

Ranked the best place to live in the UK (The Economist Global Liveability Index, 2022), Manchester boasts world-class culture, iconic sports, a thriving music and food scene, and much more. It's not just a place to research, it's a place to call home.

Experience PhD life as part of a diverse postgraduate research community of more than 1,000 postgraduate researchers at the 29th most international university in the world (Times Higher Education, 2023).

With 93% of research activity at the University rated as 'world-leading' or 'internationally excellent' (Research Excellence Framework, 2021), you'll get the chance to have an impact on global health and science challenges.

1000+

postgraduate students

93

PhDs

6

ranked in UK - QS (2025)

Manchester  United Kingdom

main campus

About Faculty of Biology, Medicine and Health

At Manchester, postgraduate researchers are at the heart of our mission to tackle pressing global challenges in biological, medical and healthcare sciences - and you could be too.

By choosing Manchester for your postgraduate research, you’ll be joining a university with an exceptional research reputation, where 93% of research is world-leading or internationally excellent (REF, 2021) and where your work will have real-world impact.

You’ll research in world-class facilities alongside leading experts at the forefront of innovation, collaborating across disciplines to pioneer new treatments, advance scientific knowledge, and improve healthcare globally.

Supported by our dedicated Doctoral Academy and strong industry links, you'll experience PhD life in a vibrant, welcoming and diverse postgraduate research community.

And you’ll leave with the specialist knowledge, research experience and transferable skills that will shape your future in academia, research or industry.


Main campus

The University of Manchester

Manchester

North West

United Kingdom

PhD saved sucessfully

(MB-PhD) Gene regulatory networks driving metastatic progression in oesophageal adenocarcinoma

Oesophageal adenocarcinoma (OAC) incidence is increasing and yet survival rates remain very poor. There are limited treatment options, especially for metastatic disease, which is especially problematic as patients usually present with late stage disease. Read more
More details

(MB-PhD) MYST Histone Acetyltransferases as Therapeutic Targets in Acute Myeloid Leukaemia

Cytotoxic chemotherapy has been the standard of care for treatment of acute myeloid leukaemia (AML) for the last 50 years. Unfortunately, more often than not, it fails to cure patients, and the 5 years survival rate for all-comers with AML is only around 20%. Read more
More details

(MB-PhD)Immunomodulation in multiple myeloma

Multiple myeloma is a devastating B-cell malignancy for which there is no cure. The development of immunomodulatory drugs (IMiDs) has proved transformative to multiple myeloma care, however, their remain unanswered questions related to the mechanism of action of this important drug class. Read more
More details

A novel role in mitochondrial homeostasis for the anti-ageing factor RBBP5

The mitochondrion has evolved from the endosymbiotic interaction of an alpha-proteobacterium and an archaeon. One major event during this evolution was the transferring of genes from the symbiont to the host. Read more
More details